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RelB Is Essential for the Development of
Myeloid-Related CD8a2 Dendritic Cells but Not
of Lymphoid-Related CD8a1 Dendritic Cells
Wu et al., 1995, 1996). This pathway begins with an
apparently lymphoid-restricted progenitor and the prog-
eny DC express certain lymphocyte markers. The my-
eloid cell growth factor GM-CSF is not required for the
production of these lymphoid-related DC, neither in vivo
Li Wu,*§ Angela D'Amico,* Kenneth D. Winkel,*
Mark Suter,*² David Lo,³ and Ken Shortman*
*The Walter and Eliza Hall Institute
of Medical Research
Post Office Royal Melbourne Hospital
Victoria 3050 (Vremec et al., 1997) nor in vitro (Saunders et al., 1996).
In the mouse, the DC derived from these differentAustralia
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Zurich 8057 guished, the CD8a1DEC-2051CD11b2 and CD8a2DEC-
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a capacity to activate T cells, but they differ in certain
regulatory features, the CD8a1 lymphoid-related DC in-
ducing T cell apoptosis and a restricted T cell cytokineSummary
output compared to the CD8a2 DC (Kronin et al., 1996;
SuÈ ss and Shortman, 1996). The molecular mechanismsThe transcription factor RelB had been shown to be
that control the development and function of these dis-important for dendritic cell (DC) development, but the
tinct DC types are therefore of particular interest.type of DC involved was not clear. Here, we report
The transcription factor RelB is a member of NF-kB/that RelB mRNA is expressed strongly in CD8a2DEC-
Rel family. RelB mRNA was found to be expressed only2052 DC but only weakly in CD8a1DEC-2051 DC. In
in lymphoid tissues and localized in the interdigitatingaddition, CD8a1DEC-2051 DC are present and func-
DC (Carrasco et al., 1993). RelB gene-targeted mutanttional in RelB null mice, the DC deficiency being mainly
mice were reported to lack DC in the thymus and spleenin the CD8a2DEC-2052 population. By constructing
and to have impaired antigen-presenting cell functionbone-marrow chimeric mice, we demonstrate that
and impaired cellular immunity (Burkly et al., 1995; Weihthe partial deficiency in RelB null thymic DC is a sec-
et al., 1995). They lacked thymic medullary epitheliumondary effect of disrupted thymic architecture. How-
and a normal medullary structure (Burkly et al., 1995).ever, the deficiency in splenic CD8a2DEC-2052 DC is
These mice displayed multi-organ inflammation, spleno-a direct, stem cell intrinsic effect of the RelB mutation.
megaly, and myeloid hyperplasia in the bone marrowThus, RelB selectively regulates a myeloid-related DC
(Burkly et al., 1995; Weih et al., 1995). However, lymphoidlineage.
cell development appeared to progress in a normal fash-
ion in these mutant mice, although abnormalities in B
and T cell function were noted in older animals (SnapperIntroduction
et al., 1996; Weih et al., 1997).
In view of these reports of DC deficiency, we wereIt has been proposed that there are at least three pathways
that lead to dendritic cell (DC) production (Shortman surprised to be able to extract DC with efficient antigen-
presenting function from the spleens of RelB mutantand Caux, 1997; Steinman et al., 1997; Banchereau and
Steinman, 1998). One corresponds to the Langerhans' mice. Accordingly, we studied in more detail the effects
of the RelB mutation on the different subtypes of DCcell lineage and may be produced in culture from human
CD341 progenitors in the presence of GM-CSF and present in normal mice. We find that RelB is required
for the development of only one DC population, whichTNFa (Caux et al., 1996); this pathway involves a com-
mitted progenitor that expresses the cutaneous lympho- normally expresses 6-fold-higher levels of RelB mRNA
than other DC populations. RelB therefore has a differ-cyte antigen (CLA) (Strunk et al., 1996). The second path-
way represents the DC closely related to monocytes ential control function, regulating the development of
only one class of DC.and macrophages, and these DC may also be produced
from the CD341 progenitors in the presence of GM-CSF
and TNFa; this pathway involves a progenitor transiently Results
expressing CD14 and other markers of phagocytic cells
including CD13, CD33, and CD36 (Caux et al., 1996). Dendritic Cells Are Found at Low Levels
Distinct from these myeloid-derived lineages is a third in the Thymus of RelB Mutant Mice
pathway, a lymphoid-related DC lineage, described in The thymus of RelB mutant mice has been reported
mouse thymus by our laboratory (Ardavin et al., 1993; previously to lack DC and medullary epithelial cells,
based on immunohistochemical staining on tissue sec-
tions (Burkly et al., 1995). T cell development appeared§ To whom correspondence should be addressed (e-mail: wu@
wehi.edu.au). to be normal, although overall thymus cellularity was
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Figure 1. A Comparison of Surface Phenotype of Thymic DC from Wild-Type and RelB Mutant Mice
Thymic DC were extracted and enriched from wild-type and RelB mutant thymus and then immunofluorescent stained and analyzed by flow
cytometry as described in Experimental Procedures. The DC in the enriched preparations were distinguished as the MHC-class-II1 and CD11c1
cells, as shown in the boxes of Figure 1A. The expression of other surface molecules on the gated DC is shown in the remaining histograms.
(A) The expression of surface molecules characteristic of DC. (B) The expression of molecules related to DC function. Results are typical of
four such analyses. The dotted line gives the background from staining with reagents lacking only the MAb of interest.
reduced. To determine if DC were completely absent in there was a 14-fold reduction in total DC numbers com-
pared with wild-type controls, greater than the 4-foldthe RelB mutant thymus, we extracted DC using colla-
genase digestion following EDTA treatment, then used reduction in the total thymus cellularity (Table 1). How-
ever, on a per cell basis the level of thymic DC was onlya procedure that enriched DC about 100-fold, and then
finally immunofluorescence stained the preparation and 3-fold lower in the RelB2/2 thymus.
analyzed for cells expressing surface makers normally
found on thymic DC (Vremec et al., 1992; Wu et al., Presence of CD8a1DEC-2051 but Lack of
CD8a2DEC-2052 DC in the Spleens1995; Vremec and Shortman, 1997). Thymic DC normally
express both CD8a and DEC-205, less than 5% being of RelB Mutant Mice
It was originally reported that RelB mutant spleen cellsCD8a2DEC-2052. As shown in Figure 1A, a clear popula-
tion of cells with the characteristic of thymic DC, includ- had a markedly reduced antigen-presenting function in
mixed leukocyte response assays, suggesting a lack ofing high forward and side scatter, high levels of MHC
class-II and CD11c, and positive for CD8a and DEC- splenic DC (Burkly et al., 1995). To determine the extent
of effects of RelB mutation on the development of205, was found in adult RelB mutant thymus. These cells
also expressed the DC function associated molecules splenic DC, the spleens were dissociated and the DC
enriched and immunofluorescent stained as describedB7.1 (CD80), B7.2 (CD86), CD40, VCAM-1 (CD106), and
ICAM-1 (CD54) (Figure 1B). Although DC were present, above for the analysis of thymic DC. As shown in Figure
Table 1. DC Levels in the Thymus and Spleen of Rel-B1/1 and Rel-B2/2 Mice
Rel-B1/1 Rel-B2/2
Thymus Spleen Thymus Spleen
Total Cells per Organ 223 6 49 3 106 151 6 37 3 106 51 6 39 3 106 375 6 97 3 106
Total DC per Organ 4.3 6 1.4 3 105 1.6 6 0.7 3 105 0.3 6 0.2 3 105 1.3 6 0.6 3 105
Results represent the numbers of cells extracted and enriched from the organs. Values are the means 6 SD of four experiments each using
a pool of 5±8 mice.
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Figure 2. A Comparison of Surface Phenotype of Splenic DC from Wild-Type and RelB Mutant Mice
Splenic DC were extracted, enriched, stained, and gated as described in Figure 1. (A) The expression of surface molecules characteristic of
DC. (B) The expression of molecules related to DC function. Results are typical of four such analyses.
2A, a clear population of cells expressing high levels of cells in the epidermis of the mouse ears. The mutant
mice displayed 63 6 5 Langerhans cells per high-powerthe DC markers MHC class-II and CD11c was detected
in the RelB mutant spleen. However, among these DC, field of epidermal sheets, whereas the wild-type control
mice displayed 62 6 2 Langerhans cells per field. Thus,only the CD8a1DEC-2051 DC population was evident,
the CD8a2DEC-2052 DC population being almost com- this form of immature DC was not missing in the RelB
null mice, in confirmation of earlier studies (Burkly et al.,pletely absent compared to the wild-type splenic DC
distribution. The same selective deficiency of CD8a2 1995; Crowley and Lo, 1998).
DEC-2052 DC was seen when immunomagnetic bead
depletion was omitted from the DC isolation protocol,
indicating that DC were not being lost during enrichment The Defect in CD8a1 Thymic DC Is a Secondary
Effect of the RelB Mutationbecause of expression of inappropriate surface antigens.
The CD8a1DEC-2051 DC found in the RelB mutant To determine if the reduced level of thymic DC in RelB
mutant mice was a direct effect of RelB mutation orspleen expressed normal levels of DC function associ-
ated molecules, including CD80, CD86, CD40, CD54, whether it was due to the lack of normal thymus medul-
lary structure in the mutant thymus, bone marrow chime-and CD106 (Figure 2B). These CD8a1DEC-2051 DC, like
those found in the normal spleen, were also CD11b2 ric mice, in which a normal thymus medullary structure
should be provided, were constructed. Bone marrow(data not shown). The absolute number of splenic DC
in RelB mutant mice was comparable to the wild-type cells from Ly 5.2 RelB mutant mice or from Ly 5.2 wild-
controls (Table 1). However, on a per cell basis the rela- type mice were transferred into lethally irradiated normal
tive level of DC was significantly reduced due to the C57BL/6 Ly 5.1 mice. At various times after transfer, the
enlarged spleen and the 2- to 3-fold increased spleen thymi of the chimeric mice were analyzed for DC content.
cellularity of the mutant mice. These results suggested Table 2 shows the DC production from RelB mutant or
a role for RelB in the development of only one DC popu- from wild-type bone marrow in chimeric mice 4 weeks
lation, namely the CD8a2DEC-2052 DC. after transfer. The RelB2/2 bone marrow produced, at
all time points examined, equal or greater numbers of
thymic DC compared with those from normal bone mar-Presence of Epidermal Langerhans Cells
row. In both cases, most donor-derived thymic DC werein RelB Mutant Mice
CD8a1 and DEC-2051, as found in normal thymus. ThisIn view of the selective loss from lymphoid tissue of
suggested that the reduction in thymic DC numbersmyeloid-related CD8a2 DC in these mutant mice, we
rechecked the level of class II MHC bearing Langerhans observed in RelB mutant mice was due to the lack of a
Immunity
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Table 2. Dendritic Cell Production by Rel-B1/1 and Rel-B2/2 Bone Marrow Cells in Chimeric Mice
Percentage of Donor±Derived DC
Total Donor±Derived DC
Donor Cells (5 3 106/Mouse) Recipient Organ per Organ CD8a1 DEC-2051
Rel-B1/1 BM 100 6 30 3 103 97 96
Thymus
Rel-B2/2 BM 118 6 27 3 103 98 98
Rel-B1/1 BM 730 6 150 3 103 63 67
Spleen
Rel-B2/2 BM 910 6 270 3 103 90 93
Results represent the numbers of donor-derived DC in the thymus and spleen of the bone marrow chimeric mice. Values are the means 6
SD of three experiments each using a pool of 5±8 recipient mice taken 4 wk post transfer. The proportion of donor-derived CD8a1 and DEC-
2051 DC is presented as a percentage of total donor-derived DC, respectively.
normal thymic medullary structure rather than a defect of DC were produced by the RelB mutant and wild-
type bone marrow cells in the spleens of chimeric mice,in thymic-type DC development inherent to the RelB2/2
stem cells. almost all RelB2/2 bone marrow±derived splenic DC
were CD8a1DEC-2051. This represents a 10-fold re-
duction in CD8a2DEC-2052 DC, compared to wild-typeThe Defect in Development of Splenic
CD8a2DEC-2052 DC Is a Direct bone marrow±derived splenic DC that had a near equiva-
lent distribution of the two DC populations. Wild-typeEffect of RelB Mutation
To determine if the defect in spleen CD8a2DEC-2052 bone marrow produced a distribution of DC subpopula-
tions close to that in normal spleen (Figure 2A). SimilarDC was likewise a secondary effect of the RelB mutation,
the same bone marrow chimeric mice described above results to these at 4 weeks were obtained even 6 weeks
after bone marrow transfer (data not shown), showingwere examined for levels of different splenic DC popula-
tions at various times after bone marrow transfer. As that the markedly reduced CD8a2DEC-2052 DC pro-
duction by RelB mutant bone marrow was not due toshown in Table 2 and Figure 3, although similar numbers
Figure 3. A Comparison of Wild-Type Bone
Marrow±Derived and RelB Mutant Bone Mar-
row±Derived Splenic DC from Chimeric Mice
The bone marrow chimeric mice were con-
structed by intravenous transfer of bone mar-
row cells from wild-type (Ly 5.2) or RelB mu-
tant (Ly 5.2) mice into lethally irradiated Ly 5.1
recipient mice. Four weeks after bone marrow
transfer, the splenic DC were extracted, en-
riched, and immunofluorescent stained as
described in Experimental Procedures. The
stained cells were analyzed by flow cytome-
try, gating for donor-derived (Ly 5.21) DC
(CD11c1), as shown in the upper histograms.
The CD8a and DEC-205 distribution on these
gated, donor-derived DC is shown in the
lower profiles.
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slower developmental kinetics. These results indicate
that the defect in production of CD8a2DEC-2052 DC in
RelB mutant mice was a direct effect on DC develop-
ment, inherent to the stem cells.
Splenic CD8a2DEC-2052 DC Express
Higher Levels of RelB mRNA Than
CD8a1DEC-2051 DC
A possible explanation for the differential effect of the
RelB mutation could be differences in functional require-
ments and levels of RelB expression among different DC
populations. A higher RelB-expressing DC population
would be predicted to be the main target of the RelB Figure 4. RelB mRNA Expression in Different DC Populations
mutation. To examine this, purified total thymic DC and Thymic DC and splenic CD8a1 and CD8a2 DC populations were
splenic CD8a1 and CD8a2 DC populations from normal purified from normal C57BL/6 mice. mRNA was extracted from the
mice were analyzed for their expression of RelB mRNA, purified DC populations. The first-strand DNA was synthesized and
PCR performed with specific oligo primers for RelB or b-actin asusing RT-PCR. As shown in Figure 4, when the same
described in Experimental Procedures. PCR products were sepa-amount of cDNA from each DC population was amplified
rated on a 2% agarose gel, transferred onto a Zeta-probe mem-for RelB, the CD8a2 splenic DC population showed sig-
brane, and hybridized with specific oligo probes for RelB or for
nificantly higher levels of RelB expression than the
b-actin. The intensity of each PCR product band was measured as
CD8a1 splenic DC population or the thymic DC (which in Experimental Procedures. The figure shows an ethidium bromide
are predominantly CD8a1). When the intensity of the stained agarose gel with the PCR products. The mRNA from normal
thymocytes and from RelB mutant thymocytes were used as positiveRelB PCR product bands was measured, the level of
and negative controls, respectively, for RelB expression. The ratiosRelB expression in CD8a2 splenic DC population was
of intensities of the RelB product band to the b-actin band from6-fold higher than that of CD8a1 splenic DC and of
each sample are indicated at the bottom of the figure.
thymic DC. A low-intensity band of RelB PCR product
was detected in the splenic CD8a1 DC and in thymic DC.
5D), except that the proliferation of CD8 T cells overallThis may reflect a reduced but still definite expression by
was not as high as that of CD4 T cells in these assays.the CD8a1 DC or merely an incomplete separation of
To test if the multi-focal inflammation in RelB mutantthe different DC lineages.
mice had produced any secondary effects on DC func-
tion, RelB mutant bone marrow±derived DC isolated
from the chimeric mice, in which the massive inflamma-The CD8a1DEC-2051 Splenic DC in RelB
Mutant Mice Display a Normal tion was not detected, were analyzed for their function.
As shown in Figures 5E and 5F, DC generated from RelBAntigen-Presenting Function
Although the CD8a1DEC-2051 splenic DC population mutant bone marrow in the chimeric mice displayed an
equal, if not better, antigen-presenting capacity, whenappeared to be phenotypically normal in RelB mutant
mice, it was not clear whether their ability to present compared with DC derived from the wild-type bone
marrow.antigen and activate T cells was affected by the muta-
tion. As the basic test of DC function, a mixed leukocyte The overall conclusion was that, although a class of
DC was absent from RelB mutant mice, the remainingreaction was used. Splenic DC were purified from RelB
mutant mice or from wild-type control mice, both of CD8a1DEC-2051 DC displayed normal function that was
not noticeably affected by the multi-focal inflammationC57BL/6 background. Various numbers of these purified
DC were cocultured, in the presence of IL-2, with CD41 or other microenvironmental changes.
or CD81 T cells isolated from lymph nodes of BALB/c
mice, and the proliferative response measured. As Discussion
shown in Figure 5A, the total splenic DC isolated from
RelB mutant mice showed a definite but reduced ability Our previous work has demonstrated the existence of
at least two different types of DC in adult mouse spleento stimulate CD4 T cell proliferation, compared to the
total splenic DC from the wild-type controls. (Vremec et al., 1992; Wu et al., 1996; Vremec and
Shortman, 1997). These different DC express differentHowever, the subpopulation distribution was different
in these preparations, and we have shown previously cell surface molecules (CD8a2DEC-2052CD11b1 versus
CD8a1DEC-2051CD11b2), appear to derive from differ-that the CD8a2DEC-2052 splenic DC, missing from the
RelB mutant spleens, are more efficient at stimulating ent precursor populations (lymphoid versus myeloid)
(Ardavin et al., 1993; Shortman and Wu, 1996; Shortmanproliferation of CD4 T cells in such assays (SuÈ ss and
Shortman, 1996). Accordingly, the CD8a1DEC-2051 DC and Caux, 1997), require different cytokines for their
development (Saunders et al., 1996; Shortman andpopulation was isolated from both normal and mutant
mice and compared directly. Under these conditions, Caux, 1997), and exhibit differences in biological func-
tion (Kronin et al., 1996; SuÈ ss and Shortman, 1996). Wethe CD8a1DEC-2051 DC from the mutant spleen showed
a similar stimulatory activity to the wild-type controls have already demonstrated that, although the develop-
ment of both DC types is dependent on members of the(Figure 5C). Similar results were obtained when CD8 T
cells were used as responding cells (Figures 5B and Ikaros transcription factor family, there is a differential
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Figure 5. T Cell Stimulatory Capacity of the
Splenic DC Populations from Wild-Type and
from RelB Mutant Mice
CD41 or CD81 lymph node T cells from
BALB/c mice were cultured with DC from
wild-type or RelB mutant mice (C57BL/6) in
the presence of IL-2 (20 ng/ml). The prolifera-
tive response was measured at day 4 by 3H-
TdR incorporation. The squares represent DC
of wild-type origin and the circles represent
DC of RelB mutant origin. (A) and (B) show
CD41 and CD81 T cell responses to total
splenic DC isolated directly from wild-type or
RelB mutant mice. (C) and (D) show T cell
responses to CD81 splenic DC population pu-
rified from wild-type or RelB mutant mice. (E)
and (F) show the T cell responses to the CD81
splenic DC derived from wild-type or from
RelB mutant bone marrow, purified from the
bone marrow chimeric mice.
control with an Ikaros null mutation allowing some previously shown to be expressed by the CD11c1
CD11b11CD8a2 DC but not by the CD11c1CD11b2production of the CD8a1DEC-2051 DC population but
preventing development of the CD8a2DEC-2052 DC CD8a1 DC of Flt3L treated mouse spleen (Pulendran et
al., 1997). These findings are therefore in accord with(Wu et al., 1997). The present study now demonstrates
that RelB also differentially controls production of our present study showing a differential effect of the
RelB mutation, with the myeloid-related splenic CD8a2CD8a2DEC-2052 DC but with a greater DC lineage se-
lectivity than Ikaros. DEC-2052 DC being absent.
The absence of the CD8a2DEC-2052CD11c1 DC sur-The earlier studies (Burkly et al., 1995; Weih et al.,
1995; Crowley and Lo, 1998) reported a markedly re- face phenotype is unlikely to be a result of the gene
insertion in this particular RelB mutant (Burkly et al.,duced DC incidence in the lymphoid tissues of the RelB
null mice, indicating that RelB was important for DC 1995) simply increasing CD8a and DEC-205 gene ex-
pression, since the additional marker of the myeloid-development. However, skin Langerhans cells appeared
to be normal in these mutant mice (Burkly et al., 1995; related DC, CD11b, was absent from these DC in our
study, as was 33D1 in a separate study (Crowley andCrowley and Lo, 1998), a finding we now confirm. We
have not determined the downstream effects of the RelB Lo, 1998). The lack of this myeloid-related DC population
agrees with our current finding that RelB mRNA is differ-mutation on the maturation and migration of these Lang-
erhans cells, since the lymph nodes in the RelB null entially expressed in the different DC populations, with
very high levels only in the CD8a2DEC-2052CD11c1 DCmice are poorly developed. Even though lymph nodes
are present in the chimeric mice, it is not clear what that are absent from the mutant mice. This points to a
direct involvement of RelB in their development.markers will adequately discriminate the various DC lin-
eages and selectively mark those derived from Langer- It was crucial to test directly if the absence of splenic
CD8a2DEC-2052 DC and the reduction in thymic DChans cells. Work is in progress on these issues. The
persistence of Langerhans cells does, however, point numbers was a direct effect of the RelB mutation or was
a secondary effect caused by the multi-organ inflamma-to a differential effect of RelB on different types of DC.
In contrast to the early studies, some DC have recently tion or the lack of thymic medullary epithelium. To this
end, bone marrow chimeric mice were constructed andbeen detected in RelB mutant spleens, although the
major 33D11 DC population was absent (Crowley and the capacity of the hemopoietic stem cells and precursor
cells from the RelB mutant mice studied in a normalLo, 1998). This missing DC population probably cor-
responds to our myeloid-related DC, since 33D1 was microenvironment. The use of the Ly 5 marker to track
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the progeny cells was important, to clearly distinguish molecule that directly controls the development of the
splenic myeloid-related, more stimulatory type of DCdonor- and host-derived DC, since a small number of
host-type of DC (including both the CD8a1DEC-2051 but is dispensable for the development and function of
the lymphoid-related CD8a1DEC-2051 DC. It is not yetand CD8a2DEC-2052 DC populations) were produced
in these chimeric mice prolonged periods (.4 weeks) clear whether the RelB deficit affects the early develop-
ment of myeloid-related DC or their later maturation orafter bone marrow transfer. The results showed that the
RelB mutant stem cells or precursor cells are capable simply the capacity of their immature forms to home to
lymphoid tissue. How much of the multi-organ inflamma-of producing normal numbers of DC in a normal thymic
environment; these DC are all CD8a1DEC-2051, as in a tion and the disrupted cellular and humoral responses
of the RelB-deficient mice is a direct consequence ofnormal thymus. The RelB mutant precursor cells also
produce normal numbers of CD8a1DEC-2051 DC in the this altered DC subset representation is not clear, since
RelB may have regulatory effects on other cell lineages.spleen but produce very few CD8a2DEC-2052 DC, the
latter in contrast to normal bone marrow precursors. To dissect out the immunological consequences of the
differential lack of myeloid-related DC in lymphoid or-The defect in thymic DC in RelB null mice was there-
fore due to the disrupted thymic structure and the defect gans, additional experimental manipulations will be
needed, including the construction of appropriate bonein thymic medullary epithelium. It appears that RelB
mutant stem cells are capable of producing CD8a1 marrow chimeric mice and infusion of normal T or B
cells. The RelB-deficient mice do, however, provide aDEC-2051 DC in either the thymus or the spleen, given
a normal environment. In contrast, the RelB mutant stem useful tool for further exploration of both the develop-
ment and function of particular DC lineages.cells do not produce in lymphoid organs a significant
number of CD8a2DEC-2052, myeloid-type DC, even in
a normal environment and even if the time after bone Experimental Procedures
marrow transfer is prolonged. It has been suggested
Micethat the lack of certain splenic DC in the RelB mutant
The RelB mutant C57BL/6 mice were originally generated in D. Lo'smice is a result of the systemic inflammation (Crow-
laboratory (Burkly et al., 1995). They were bred for three generationsley and Lo, 1998), and it has been shown that factors
onto C57BL/6J wehi mice and then the selected heterozygous mice
such as lipopolysaccharide induce DC redistribution (De bred under specific pathogen-free conditions in the animal facility
Smedt et al., 1996). This may partly account for a loss of the Walter and Eliza Hall Institute. The homozygous RelB2/2 were
selected and wild-type RelB1/1 littermates used for all comparisons.of DC at a later stage, after severe inflammation devel-
These mice, male and female, were used at 5±8 weeks of age forops in these mice. However, we found plentiful CD8a1
DC analysis or as donors for constructing bone marrow chimericDEC-2051 DC but few CD8a2DEC-2052 DC even in the
mice. C57BL/6 Ly 5.1-Pep3b mice were used at 8±12 weeks of agespleen of young adult mutant mice. The results with the
as recipients in bone marrow chimeric mice experiments.
bone marrow chimeras now demonstrate that this is a
defect in CD8a2DEC-2052 DC development that is a MAbs and Fluorescent Reagents
direct consequence of the RelB mutation and is stem The MAbs, the hybridoma clones, and the fluorescent reagents used
cell autonomous. for depletion and for immunofluorescent labeling were all as speci-
fied elsewhere (Vremec et al., 1992; Wu et al., 1996). In brief, theIn view of the earlier studies indicating little T cell
fluorescence-conjugated antibodies used for DC staining werestimulating capacity by the spleen cells of the RelB
FITC-conjugated or biotinylated anti-CD11c (clone N418), phycoer-mutant mice (Burkly et al., 1995), it was important to
ythrin (PE)- or Cy5-conjugated anti-CD8a (clone 53.6 or YTS169.4),
test the functional capacity of the DC that we found Texas-Red-conjugated anti-MHC class II (clone N22), biotinylated
to be present. The capacity of these RelB2/2 CD8a1 anti-DEC2205 (clone NLDC-145), biotinylated-anti-B7.1 (clone 16±
DEC-2051 DC to interact with T cells appeared normal, 10A1), biotinylated-anti-B7.2 (clone GL1), biotinylated-anti-CD40
(clone FGK45.1), biotinylated-anti-CD54 (clone YN1/1.7.4), and bio-when they were purified from the spleens of either mu-
tinylated-anti-CD106 (clone 429), with PE-avidin or Texas-Red-avi-tant mice or chimeric mice and compared to normal
din being used as the second stage. For bone marrow transferCD8a1DEC-2051 DC. This indicates that RelB was not
experiments, FITC-anti-Ly 5.2 (clone AL1-4A2) was used for staining
crucial for the function of this DC type. The markedly donor type cells.
reduced antigen-presenting cell activity of the mutant
spleen population overall probably had three causes: DC Enrichment and Surface Phenotype Analysis
(1) the missing CD8a2DEC-2052 splenic DC population Pools of thymi or spleens were used for DC extraction and analysis,
is more stimulatory in an allo-MLR than the CD8a1 as described in detail elsewhere (Vremec et al., 1992; Wu et al.,
1996; Vremec and Shortman, 1997). The organs were chopped, di-DEC-2051 DC, since the latter exhibit several regulatory
gested with collagenase, and treated with EDTA. Light density cellseffects on the T cells they activate (Kronin et al., 1996;
were collected by a density centrifugation procedure. Non-DC lin-SuÈ ss and Shortman, 1996); (2) on a per cell basis, the
eage cells were normally then depleted from the light-density cells
DC incidence in the mutant spleens is reduced due to by coating them with a mixture of monoclonal antibodies (Vremec
increased levels of other cells; and (3) the elevated levels and Shortman, 1997) and then depleting the coated cells with mag-
of macrophage and granulocytes in the mutant spleens netic beads coupled to anti-rat-IgG. (In some experiments immuno-
magnetic bead depletion was omitted, allowing higher recovery butmay have an inhibitory effect on the T cell responses,
reduced purity of DC; the results so obtained were unaltered.) Theunless the DC are first isolated and purified.
DC enriched preparations (z70% DC) were then immunofluorescentOverall, this study indicates that the defect in DC
stained in four colors with a combination of fluorescent-conjugatedpopulation in RelB mutant mice is a combination of cell-
antibodies against DC markers and function related molecules, as
autonomous and extrinsic RelB dependent events. The described above. Propidium iodide (PI) was added in the final wash
defect in thymic DC is a consequence of a disrupted to label dead cells. During cytometric analysis, the cells were gated
for DC characteristics (high forward and side scatter) with PI labeledthymic structure. However, RelB appears to be a key
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dead cells excluded. In some experiments in which only limited number of bright-staining cells with typical dendritic morphology
counted on 20 high-power fields. To prepare the sheets, ears fromnumber of cells from the recipient thymi were available, the tissues
were digested with collagenase and treated with EDTA, the light 3±5 mice were removed and soaked for 1 hr at 378C in a salt solution
containing 3% EDTA. The ears were then split and the epidermaldensity cells were collected as above, but the immunomagnetic
bead depletion procedure was omitted. The proportion of DC was layer removed into BSS. The epidermal sheets were dehydrated in
acetone for 10 min at room temperature, then rehydrated in BSSthen lower in such preparations but the gating for MHC class II and
CD11c served to distinguish the DC. The stained cells were then prior to incubation overnight at 48C with the fluorescent anti-class
II MHC. The epidermal sheets were then washed twice in BSS (5analyzed on a FACStar-Plus instrument (Becton Dickinson, San
Jose, CA). min, room temperature) before mounting on slides for fluorescence
microscopy.
Generation of Bone Marrow Chimeras
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